Pratima Chowdary

9.5k total citations · 1 hit paper
161 papers, 3.7k citations indexed

About

Pratima Chowdary is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Pratima Chowdary has authored 161 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Hematology, 33 papers in Genetics and 16 papers in Molecular Biology. Recurrent topics in Pratima Chowdary's work include Hemophilia Treatment and Research (119 papers), Blood Coagulation and Thrombosis Mechanisms (48 papers) and Platelet Disorders and Treatments (36 papers). Pratima Chowdary is often cited by papers focused on Hemophilia Treatment and Research (119 papers), Blood Coagulation and Thrombosis Mechanisms (48 papers) and Platelet Disorders and Treatments (36 papers). Pratima Chowdary collaborates with scholars based in United Kingdom, United States and Germany. Pratima Chowdary's co-authors include Anne Riddell, Susan Mallett, Nicola J. Mutch, Claire S. Whyte, Joanne Mitchell, Gael B. Morrow, Mary Mathias, Víctor Jiménez‐Yuste, Andrew K. Burroughs and Pantep Angchaisuksiri and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Pratima Chowdary

149 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

2023 100 citations Annette von Drygalski, Pratima Chowdary et al. profile →

Peers

Countries citing papers authored by Pratima Chowdary

Since Specialization

Citations

This map shows the geographic impact of Pratima Chowdary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pratima Chowdary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pratima Chowdary more than expected).

Fields of papers citing papers by Pratima Chowdary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pratima Chowdary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pratima Chowdary. The network helps show where Pratima Chowdary may publish in the future.

Co-authorship network of co-authors of Pratima Chowdary

This figure shows the co-authorship network connecting the top 25 collaborators of Pratima Chowdary. A scholar is included among the top collaborators of Pratima Chowdary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pratima Chowdary. Pratima Chowdary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factor VIII Antibodies Demonstrate Type I or Type II Kinetics in Acquired Haemophilia A 2025 ·Haemophilia ·(unknown), (unknown), Anne Riddell, Pratima Chowdary, Paul Batty	2
2	Gap Analysis Investigating Healthcare Professionals’ Skills and Knowledge for Pain Management in Haemophilia—A Qualitative Study 2025 ·Haemophilia ·Paul McLaughlin, Pratima Chowdary, Catherine Harrison, David Stephensen, Nathalie Roussel	0
3	Disease Burden, Clinical Outcomes, and Quality of Life in People with Hemophilia A without Inhibitors in Europe: Analyses from CHESS II/CHESS PAEDs 2024 ·SHILAP Revista de lepidopterología ·Pratima Chowdary, Richard Ofori‐Asenso, Francis Nissen, (unknown), (unknown), (unknown), Tom Burke, Beatrice Nolan, Jamie O’Hara, Kate Khair	0
4	Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy 2024 ·Journal of Thrombosis and Haemostasis ·Wolfgang Miesbach, Barbara A. Konkle, Pratima Chowdary, Radosław Kaczmarek, Frank W.G. Leebeek, Johnny Mahlangu, (unknown), Steven W. Pipe, Alok Srivastava, Jan Voorberg, Glenn F. Pierce, Flora Peyvandi	5
5	A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B 2023 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), (unknown), Frank W.G. Leebeek, Karin Fijnvandraat, Michiel Coppens, Mary Mathias, Peter W. Collins, Robert C. Tait, Catherine Bagot, Nicola Curry, Jeanette Payne, Pratima Chowdary, Marjon H. Cnossen, Ron A. A. Mathôt	3
6	OC 69.5 Outcomes in Adult and Adolescent Patients with Severe Hemophilia a in the Phase 3 XTEND-1 Study Who Switched to Efanesoctocog Alfa Prophylaxis from an Observational Study with Factor VIII Prophylaxis 2023 ·Research and Practice in Thrombosis and Haemostasis ·Sophie Susen, Roshni Kulkarni, Keiji Nogami, Flora Peyvandi, Barbara A. Konkle, Elena Santagostino, Usman Khan, Annemieke Willemze, (unknown), Jennifer Dumont, Pratima Chowdary	1
7	Laboratory coagulation tests and recombinant porcine factor VIII: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline 2022 ·Haemophilia ·Annette Bowyer, Elaine Gray, (unknown), Paul Murphy, Sean Platton, Anne Riddell, Pratima Chowdary, Will Lester, P. Vincent Jenkins	8
8	Multidisciplinary Team Care of Patients with Hemophilic Arthropathy: A Qualitative Assessment of Contemporary Practice in the UK and Canada 2022 ·Clinical and Applied Thrombosis/Hemostasis ·Jean St‐Louis, Pratima Chowdary, G. Dolan, Dawn Goodyear, (unknown), Debra Pollard, Jerry Teitel	6
9	Post‐hoc analysis on the long‐term response to fixed‐dose prophylaxis with N8‐GP in patients with haemophilia A 2021 ·Haemophilia ·Andreas Tiede, K. K. Hampton, Víctor Jiménez‐Yuste, Guy Young, (unknown), Pratima Chowdary	0
10	Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study 2021 ·Blood Advances ·Paul van der Valk, Michael Makris, Kathelijn Fischer, Robert C. Tait, Pratima Chowdary, Peter W. Collins, Karina Meijer, Lize F. D. van Vulpen, Eveline P. Mauser‐Bunschoten, Roger E. G. Schutgens	18
11	Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study 2021 ·Blood ·Claude Négrier, Johnny Mahlangu, Michaela Lehle, Pratima Chowdary, Olivier Catalani, Víctor Jiménez‐Yuste, Benjamin M. Beckermann, Christophe Schmitt, Cédric Hermans, (unknown), Jerzy Windyga, Anna Kiialainen, Roseline d’Oiron, Paul Moorehead, (unknown), Amy D. Shapiro, Johannes Oldenburg	7
12	A WITHIN-PATIENT COMPARISON OF EFFICACY AND OUTCOME OF RECOMBINANT FIX AND FIXFC IN HAEMOPHILIA B IN THE UK 2020 ·Haemophilia ·(unknown), M.J. Scott, C. R. M. Hay, Peter W. Collins, Hua Xiang, Susan Shapiro, Pratima Chowdary, Emily Symington, Richard Gooding, (unknown)	2
13	Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline 2019 ·Haemophilia ·P. Vincent Jenkins, Annette Bowyer, (unknown), Elaine Gray, Steve Kitchen, Paul Murphy, Sean Platton, Anne Riddell, Pratima Chowdary, Will Lester	51
14	Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline 2019 ·Haemophilia ·Elaine Gray, Steve Kitchen, Annette Bowyer, Pratima Chowdary, P. Vincent Jenkins, Paul Murphy, Sean Platton, Anne Riddell, Will Lester	36
15	Phase 1, single‐dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia 2018 ·Journal of Thrombosis and Haemostasis ·Ralph A. Gruppo, Daniel R Malan, J. Kapocsi, László Nemes, C. R. M. Hay, Lisa Boggio, Pratima Chowdary, Giuseppe Tagariello, Annette von Drygalski, Fei Hua, Matthew Scaramozza, Steven Arkin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	17
16	Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing "Empty Viral Particles" on Safety and Efficacy of Gene Transfer 2018 ·Blood ·Amit C. Nathwani, Ulrike M. Reiss, Edward G. D. Tuddenham, Pratima Chowdary, Jenny McIntosh, Anne Riddell, (unknown), Johnny Mahlangu, Michael Recht, Yu‐Min Shen, Kathleen G. Halka, Michael M. Meagher, Arthur W. Nienhuis, Andrew M. Davidoff, Sarah Mangles, (unknown), Junfang Zhou, (unknown)	94
17	P15.09: Multicentre retrospective study to assess diagnostic accuracy of ultrasound for superficial endometriosis: are we any closer? 2016 ·Ultrasound in Obstetrics and Gynecology ·(unknown), (unknown), Pratima Chowdary, Emma Readman, (unknown), (unknown), (unknown), (unknown), Lenore Ellett	1
18	Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glycoPEGylated factor IX 2016 ·Haemophilia ·Miguel A. Escobar, Ramin Tehranchi, Faraizah Abdul Karim, (unknown), Pratima Chowdary, T. Colberg, Paul Giangrande, Adam Giermasz, Maria Elisa Mancuso, M. Şerban, Woei Tsay, Johnny Mahlangu	21
19	Efficacy and safety of OBI‐1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A 2015 ·Haemophilia ·Rebecca Kruse‐Jarres, Jean St‐Louis, A. Greist, Amy Shapiro, Hedy Smith, Pratima Chowdary, (unknown), Edward D. Gomperts, C. Bourgeois, Min Mo, (unknown), (unknown), Bruce M. Ewenstein	128
20	Cardiovascular disease history and risk factors in hemophilia patients 2012 ·Haemophilia ·(unknown), Kathelijn Fischer, Michael Makris, Christopher Tait, Pratima Chowdary, Peter W. Collins, Karina Meijer, G. Roosendaal, Roger E. G. Schutgens, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact